Aquasomes - A nanoparticulate approach for the delivery of antigen

Drug Development and Industrial Pharmacy

Volumn 34, Issue 12, 2008, Pages 1297-1305

  Goyal, Amit K ^a   Khatri, Kapil ^a   Mishra, Neeraj ^a   Mehta, Abhinav ^a   Vaidya, Bhuvaneshwar ^a   Tiwari, Shailja ^a   Vyas, Suresh Prasad ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Aquasomes; Bovine serum albumin; Cellobiose; Hydroxyapatite; Nanoparticles; Trehalose; Vaccines

Indexed keywords

ANTIGEN; AQUASOME; BOVINE SERUM ALBUMIN; CELLOBIOSE; HYDROXYAPATITE; HYDROXYL GROUP; NANOCARRIER; NANOPARTICLE; OLIGOMER; TREHALOSE; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRECIPITATION; TH1 CELL; TH2 CELL;

ANIMALS; CELLOBIOSE; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DURAPATITE; FEMALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; SERUM ALBUMIN, BOVINE; TREHALOSE;

EID: 57349158687     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802071661     Document Type: Article

References (30)

1. Arakawa, T., & Timsheff, S. N. (1992). Stabilization of protein structure by sugars. Biochemistry, 21, 6536-6544.
2. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y., Pulendran, B., & Palucka, K., (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol., 8, 767-811.
3. Brandau, D. T., Jones, L. S., Wiefthoff, C. M., Rexroad, J., & Middaugh, C. R. (2003). Thermal stability of vaccines. J. Pharm. Sci., 92(2), 218-231.
4. Brennan, F. R., & Dougan, G. (2005). Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies. Vaccine, 23, 3210-3222.
5. Carpenter, J. F., Crowe, J. H., & Arakawa, T. (1986). Comparison of solute-induced protein stabilization in aqueous solution and in the frozen and dried states. J. Dairy Sci., 73, 3627-3636.
6. Davis, B. G., & Robinson, M. A. (2002). Drug delivery systems based on sugar-macromolecule conjugates Curr. Opin. Drug Discov. Devel., 5(2), 279-288.
7. Goyal, A. K., Rawat, A., Mahor, S., Gupta, P. N., Khatri, K., & Vyas, S. P. (2006). Nanodecoy system: a novel approach to design hepatitis B vaccine for immunopotentiation. Int. J. Pharm., 309, 227-233.
8. Gupta, P. N., Mishra, V., Rawat, A., Dubey, P., Mahor, S., Jain, S., Chatterji, D. P., & Vyas, S. P. (2005). Noninvasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int. J. Pharm., 293, 73-82.
9. Gupta, R. K., & Siber, G. R. (1995). Adjuvants for human vaccines: current status, problems and future prospects. Vaccine, 13, 1263-1276.
10. Hatley, R. H. M., & Blair, J. A., (1999). Stabilisation and delivery of labile materials by amorphous carbohydrates and their derivatives. J. Mol. Catal., B Enzym., 7, 11-19.
11. He, Q., Mitchell, A. R., Johnson, S. L., Bartak, C. W., Morcol, T., & Bell, S. J. D. (2000). Calcium phosphate nanoparticle adjuvant. Clin. Diagn. Lab. Immunol., 7(6), 899-903.
12. Hegde, V. L., & Venkatesh, Y. P. (2007). Generation of antibodies specific to D-mannitol, a unique haptenic allergen, using reductively aminated D-mannose-bovine serum albumin conjugate as the immunogen. Immunobiology, 212, 119-128.
13. Hillman, M. R. (2002). Overview of the needs and realities for developing new and improved vaccines in the 21st Century. Intervirology, 45, 199-211.
14. Irma, R.-O., Rodrigo, S.-L. A., Jose, R.-G., & Carlos, Q.-B. T. (2007). Elaboration and structural analysis of aquasomes loaded with indomethacin. Eur. J. Pharm. Sci., 32(3), 223-230.
15. Jaganathan, K. S., & Vyas, S. P. (2006). Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine, 24(19), 4201-4211.
16. Khopade, A. J., Khopade, S., & Jain, N. K. (2002). Development of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer. Int. J. Pharm., 241(1), 145-154.
17. Kossovsky, N., Gelman, A., Hnatyszyn, J., Sponsler, E., & Chow, G. M. (1995). Conformationally stabilizing self-assembling nanostructured delivery vehicle for biochemically reactive pairs. Nano Struct. Mater., 5(2), 233-247.
18. Kossovsky, N., Sponsler, E., & Hnatyszyn H. J. (1993). Self-Assembling nanostructures. Biotechnology, 11, 1534-1536.
19. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature, 227, 680-685.
20. Lewis, D. J. M. (1996). Design and production of single-immunization vaccines using poly-(lactic)-co-(glycolic) acid microsphere systems. In A. Robinsons, G. H. Farrer, & C. N. Wiblin (Eds.). Methods in molecular medicine: Vaccine protocols. (pp. 140-147). New Jersey: Humana Press.
21. Mazzobre, M. F., & Buera, M. P. (1999). Combined effects of trehalose and cations on the thermal resistance of b-galactosidase in freeze dried systems. Biochimica Biophys. Acta, 1473, 337-344.
22. Merz, R. A., Horsch, M., Ruffner, H. P., & Rast, D. M. (1999). Interaction between chitosan and concanavalin A. Phytochemistr., 52, 211-224.
23. Miller, D. P., dePablo, J. J., & Corti, H. R. (1997). Thermophysical properties of trehalose and its concentrated aqueous solutions. Pharm. Res., 14, 578-589.
24. Mishra, V., Mahor, S., Rawat, A., Dubey, P., Gupta, P. N., Singh, P., & Vyas, S. P. (2006). Development of novel fusogenic vesosomes for transcutaneous immunization. Vaccine, 24, 5559-5570.
25. O'Hagan, D. T. (2001). Recent developments in vaccine delivery systems. Curr. Drug Targets Infect. Disord., 1, 273-286.
26. Patil, S., Khopade, A. J., Nagaich, S., Agrawal, G. P., & Jain, N. K. (1999). Adsorption studies of sugars on calcium hydroxy apatite ceramics and hemoglobin on sugar-coated ceramics. Pharmazie. 54(4), 310-312.
27. Rexroad, J., Wiethoff, C. M., Jones, L. S. C., & Middaugh, R. (2002). Lyophilization and the thermostability of vaccines. Cell Preserv. Technol., 1(2), 91-104.
28. Saifuddin, M., Hart, M. L., Gewurz, H., Zhang, Y., & Spear, G. T. (2000). Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J. Gen. Virol., 81, 949-955.
29. So, L. L., & Goldstein, I. J. (1967). Application of the quantitative precipitin method to polysaccharide-concanavalin A interaction. J. Biol. Chem., 242, 1617-1622.
30. Tas, A. C. (2001). X-ray diffraction data for flux grown calcium hydroxyapatite whiskers. Powder Diffr., 16(2), 102-106.